Skip to main content
search

Conference: DayOne Innovation Showcase 2026

Date: December 15, 2026

Location: Novartis Campus, Basel, Switzerland

Booth: TBD

Proud Visibility Partner

From Breakthrough Innovation to Trusted Evidence

Drug Discovery and Development Solutions for Every Phase

Transforming promising science into successful therapies requires more than innovation. It takes the right evidence, development strategy, and regulatory expertise to make confident decisions at every stage.

Join Certara at the DayOne Innovation Showcase 2026, where biotech founders, healthcare innovators, investors, and pharmaceutical leaders come together to explore the future of healthcare innovation.

Certara combines predictive biosimulation, AI-enabled technologies, integrated drug development solutions, and regulatory expertise to help emerging companies and investors reduce uncertainty, optimize development strategies, and advance promising innovations.

Whether you’re preparing for your next funding milestone, evaluating an investment opportunity, or advancing a therapeutic program, Certara can help you make informed decisions that drive development forward.

Advancing Innovation. Reducing Risk. Creating Value.

Certara helps innovators and investors navigate complex drug development decisions with greater confidence.

Reduce Development Risk

Identify scientific, clinical, and regulatory challenges earlier through predictive modeling, integrated development planning, and evidence-driven decision-making.

Make Capital Work Harder

Focus resources on the right opportunities by optimizing development strategies, informing study design, and prioritizing investments that support critical milestones.

Build Investor and Partner Confidence

Generate credible scientific evidence and executable development strategies that strengthen investment readiness, support partnering discussions, and demonstrate asset potential.

Meet Certara's Experts at DayOne

Connect with our team to discuss how Certara’s integrated scientific, regulatory, and technology capabilities can help advance your innovation, strengthen your development strategy, and support your next milestone.

Rik de Greef, Senior Vice President, Global Quantitative Sciences Services, Certara Drug Development Solutions

Philippe Salphati, Sr. Director, Strategic Partnerships & Growth

Diane Garvey, Portfolio Account Director, Certara AI, EMEA

Jurgen Grampp, Global Account Director

Let's Connect at DayOne

Meet with Certara’s experts to explore how we can help reduce development risk, strengthen investment readiness, and accelerate your next milestone.

Explore Our Resources

Discover how Certara helps emerging biotechs, investors, and pharmaceutical innovators reduce development risk, build investment-ready programs, and make informed scientific and strategic decisions.

Bio Venture Catalyst

Accelerating Development. Strengthening Investment Readiness.

Explore how Certara helps emerging biotech companies develop integrated strategies that support funding, development milestones, and long-term asset value.

Explore Bio Venture Catalyst

Due Diligence and Asset Evaluation

Make More Informed Investment Decisions.

Discover how Certara supports venture capital firms, private equity investors, and pharmaceutical partners with independent scientific, clinical, regulatory, and commercial asset evaluations.

Explore Due Diligence and Asset Evaluation

Model-Informed Drug Development (MIDD)

Make More Confident Drug Development Decisions.

Discover how Certara’s model-informed drug development solutions integrate predictive modeling, clinical pharmacology, and regulatory expertise to optimize development strategies, inform dose selection, and support evidence-driven decisions across the drug development lifecycle.

Explore Certara’s MIDD Solutions

Pharmacometrics Services

Transform Clinical Data into Actionable Development Insights.

Explore how Certara’s pharmacometrics experts leverage population PK/PD modeling, exposure-response analysis, and clinical trial simulation to inform dosing strategies, optimize study design, and strengthen regulatory decision-making.

Explore Certara’s Pharmacometrics Services

What It Takes to Build a Fundable Biotech

On-Demand Investor Panel

Hear perspectives on what investors look for in emerging biotech companies and how scientific credibility, development planning, and investment readiness influence funding decisions.

Watch the Webinar

Building IND-Ready and Investor-Ready Development Programs

On-Demand Webinar

Learn how integrated development planning can help emerging biotech companies navigate regulatory requirements, manage risk, and prepare for critical investment and clinical milestones.

Watch the Webinar

MIDD as a Tool to Enhance Asset Value and Address Key Investor Concerns

On-Demand Webinar

Explore how model-informed drug development can strengthen scientific evidence, inform development strategy, and support investment and licensing decisions.

Watch the Webinar

Portfolio Prioritization Using Early-Stage Biosimulation and QSP

On-Demand Webinar

Discover how quantitative systems pharmacology and predictive modeling can help evaluate therapeutic opportunities, prioritize assets, and guide early development investment decisions.

Watch the Webinar